Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aeterna Zentaris presents promising compound for cancer treatment

April 5, 2012

Pfizer drug approved in Japan for ALK-positive NSCLC

April 4, 2012

Marina Biotech completes dosing second cohort in START-FAP trial

April 4, 2012

Scripps Research Institute obtains funds to study new pathway in lymphoma

April 4, 2012

Onyx Pharmaceuticals reports phase III regorafenib data

April 4, 2012

Phase III palifosfamide study advances

April 4, 2012

Hutchinson MediPharma presents potent dual PI3K/mTOR inhibitor

April 4, 2012

First stage of phase III study of Reolysin completes enrollment

April 4, 2012

FORMA Therapeutics presents novel Nampt inhibitors

April 4, 2012

AZD-8055 analogue shows promise to treat of hormone therapy-resistant tumors

April 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...